Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Mutation of FOP/FGFR1OP in mice recapitulates human short rib-polydactyly ciliopathy.

Cabaud O, Roubin R, Comte A, Bascunana V, Sergé A, Sedjaï F, Birnbaum D, Rosnet O, Acquaviva C.

Hum Mol Genet. 2018 Oct 1;27(19):3377-3391. doi: 10.1093/hmg/ddy246.

PMID:
29982567
2.

Evaluation of Selected Immunomodulatory Glycoproteins as an Adjunct to Cancer Immunotherapy.

Sekhon BK, Roubin RH, Li Y, Devi PB, Nammi S, Fan K, Sze DM.

PLoS One. 2016 Jan 22;11(1):e0146881. doi: 10.1371/journal.pone.0146881. eCollection 2016.

3.

Review Of Obesity And Atrial Fibrillation: Exploring The Paradox.

Cambeiro G, Cristina M, Mañero R, Moisés, Roubin R, Assi A, Emad, Sergio, Juanatey G, Ramón J.

J Atr Fibrillation. 2015 Aug 31;8(2):1259. doi: 10.4022/jafib.1259. eCollection 2015 Aug-Sep. Review.

4.

Ethnopharmacological and bioactivity guided investigation of five TCM anticancer herbs.

Meng QX, Roubin RH, Hanrahan JR.

J Ethnopharmacol. 2013 Jun 21;148(1):229-38. doi: 10.1016/j.jep.2013.04.014. Epub 2013 Apr 23.

PMID:
23623820
5.

PSP activates monocytes in resting human peripheral blood mononuclear cells: immunomodulatory implications for cancer treatment.

Sekhon BK, Sze DM, Chan WK, Fan K, Li GQ, Moore DE, Roubin RH.

Food Chem. 2013 Jun 15;138(4):2201-9. doi: 10.1016/j.foodchem.2012.11.009. Epub 2012 Nov 15.

PMID:
23497877
6.

Myomegalin is necessary for the formation of centrosomal and Golgi-derived microtubules.

Roubin R, Acquaviva C, Chevrier V, Sedjaï F, Zyss D, Birnbaum D, Rosnet O.

Biol Open. 2013 Feb 15;2(2):238-50. doi: 10.1242/bio.20123392. Epub 2012 Dec 18.

7.

The discovery of novel isoflavone pan peroxisome proliferator-activated receptor agonists.

Matin A, Doddareddy MR, Gavande N, Nammi S, Groundwater PW, Roubin RH, Hibbs DE.

Bioorg Med Chem. 2013 Feb 1;21(3):766-78. doi: 10.1016/j.bmc.2012.11.040. Epub 2012 Dec 3.

PMID:
23265844
8.

7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.

Matin A, Gavande N, Kim MS, Yang NX, Salam NK, Hanrahan JR, Roubin RH, Hibbs DE.

J Med Chem. 2009 Nov 12;52(21):6835-50. doi: 10.1021/jm900964r.

PMID:
19807106
9.

GARP: a key receptor controlling FOXP3 in human regulatory T cells.

Probst-Kepper M, Geffers R, Kröger A, Viegas N, Erck C, Hecht HJ, Lünsdorf H, Roubin R, Moharregh-Khiabani D, Wagner K, Ocklenburg F, Jeron A, Garritsen H, Arstila TP, Kekäläinen E, Balling R, Hauser H, Buer J, Weiss S.

J Cell Mol Med. 2009 Sep;13(9B):3343-57. doi: 10.1111/j.1582-4934.2009.00782.x. Epub 2009 May 13.

10.

Ethnobotany, phytochemistry and pharmacology of the genus Caragana used in traditional Chinese medicine.

Meng Q, Niu Y, Niu X, Roubin RH, Hanrahan JR.

J Ethnopharmacol. 2009 Jul 30;124(3):350-68. doi: 10.1016/j.jep.2009.04.048. Epub 2009 May 5. Review.

PMID:
19422901
11.

Small-scale enzymatic digestion of glycoproteins and proteoglycans for analysis of oligosaccharides by LC-MS and FACE gel electrophoresis.

Estrella RP, Whitelock JM, Roubin RH, Packer NH, Karlsson NG.

Methods Mol Biol. 2009;534:171-92. doi: 10.1007/978-1-59745-022-5_13. Review.

PMID:
19277552
12.

High-throughput screening platform for anticancer therapeutic drug cytotoxicity.

Sekhon BK, Roubin RH, Tan A, Chan WK, Sze DM.

Assay Drug Dev Technol. 2008 Oct;6(5):711-21. doi: 10.1089/adt.2008.148.

PMID:
19035851
13.

Characterization and purification of glycosaminoglycans from crude biological samples.

Davies NP, Roubin RH, Whitelock JM.

J Agric Food Chem. 2008 Jan 23;56(2):343-8. doi: 10.1021/jf072624v. Epub 2007 Dec 29.

PMID:
18163570
14.

Direct and heterologous approaches to identify the LET-756/FGF interactome.

Popovici C, Berda Y, Conchonaud F, Harbis A, Birnbaum D, Roubin R.

BMC Genomics. 2006 May 3;7:105.

15.

Intracellular trafficking of LET-756, a fibroblast growth factor of C. elegans, is controlled by a balance of export and nuclear signals.

Popovici C, Fallet M, Marguet D, Birnbaum D, Roubin R.

Exp Cell Res. 2006 May 15;312(9):1484-95. Epub 2006 Feb 20.

PMID:
16487967
16.

An evolutionary history of the FGF superfamily.

Popovici C, Roubin R, Coulier F, Birnbaum D.

Bioessays. 2005 Aug;27(8):849-57.

PMID:
16015590
17.

A pair as a minimum: the two fibroblast growth factors of the nematode Caenorhabditis elegans.

Birnbaum D, Popovici C, Roubin R.

Dev Dyn. 2005 Feb;232(2):247-55. Review.

18.

Functional phylogeny relates LET-756 to fibroblast growth factor 9.

Popovici C, Conchonaud F, Birnbaum D, Roubin R.

J Biol Chem. 2004 Sep 17;279(38):40146-52. Epub 2004 Jun 15.

19.

Caenorhabditis elegans receptors related to mammalian vascular endothelial growth factor receptors are expressed in neural cells.

Popovici C, Isnardon D, Birnbaum D, Roubin R.

Neurosci Lett. 2002 Aug 23;329(1):116-20.

PMID:
12161275
20.

let-756, a C. elegans fgf essential for worm development.

Roubin R, Naert K, Popovici C, Vatcher G, Coulier F, Thierry-Mieg J, Pontarotti P, Birnbaum D, Baillie D, Thierry-Mieg D.

Oncogene. 1999 Nov 18;18(48):6741-7.

21.

The family of Caenorhabditis elegans tyrosine kinase receptors: similarities and differences with mammalian receptors.

Popovici C, Roubin R, Coulier F, Pontarotti P, Birnbaum D.

Genome Res. 1999 Nov;9(11):1026-39.

22.

Of worms and men: an evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families.

Coulier F, Pontarotti P, Roubin R, Hartung H, Goldfarb M, Birnbaum D.

J Mol Evol. 1997 Jan;44(1):43-56.

PMID:
9010135
23.

Structure and developmental expression of mouse Garp, a gene encoding a new leucine-rich repeat-containing protein.

Roubin R, Pizette S, Ollendorff V, Planche J, Birnbaum D, Delapeyriere O.

Int J Dev Biol. 1996 Jun;40(3):545-55.

24.

Human beta-globin gene polymorphisms characterized in DNA extracted from ancient bones 12,000 years old.

Béraud-Colomb E, Roubin R, Martin J, Maroc N, Gardeisen A, Trabuchet G, Goosséns M.

Am J Hum Genet. 1995 Dec;57(6):1267-74.

25.

The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines.

Philippon V, Vellutini C, Gambarelli D, Harkiss G, Arbuthnott G, Metzger D, Roubin R, Filippi P.

Virology. 1994 Dec;205(2):519-29.

PMID:
7526541
26.

Transcriptional activation of the NCAM gene during myogenic differentiation.

Roubin R, Goridis C.

Exp Cell Res. 1992 Jun;200(2):500-5.

PMID:
1572411
27.

Evaluation of the effect of suramin on neural cell growth and N-CAM expression.

Guo XJ, Fantini J, Roubin R, Marvaldi J, Rougon G.

Cancer Res. 1990 Aug 15;50(16):5164-70.

28.

Modulation of NCAM expression by transforming growth factor-beta, serum, and autocrine factors.

Roubin R, Deagostini-Bazin H, Hirsch MR, Goridis C.

J Cell Biol. 1990 Aug;111(2):673-84.

29.

Biosynthesis of paf-acether. Paf-acether but not leukotriene C4 production is impaired in cultured macrophages.

Dulioust A, Vivier E, Meslier N, Roubin R, Haye-Legrand I, Benveniste J.

Biochem J. 1989 Oct 1;263(1):165-71.

31.

Production of PAF-acether and leukotrienes by cultured mouse macrophages.

Haye-Legrand I, Dulioust A, Vivier E, Roubin R, Benveniste J.

Pharmacol Res Commun. 1986 Aug;18 Suppl:239-42. No abstract available.

PMID:
3774848
32.

Biosynthesis of paf-acether: VIII: Impairment of paf-acether production in activated macrophages does not depend upon acetyltransferase activity.

Roubin R, Dulioust A, Haye-Legrand I, Ninio E, Benveniste J.

J Immunol. 1986 Mar 1;136(5):1796-802.

PMID:
3950403
33.

Formation of prostaglandins, leukotrienes and paf-acether by macrophages.

Roubin R, Benveniste J.

Comp Immunol Microbiol Infect Dis. 1985;8(2):109-18. Review.

PMID:
3910339
34.

Paf-acether generates chemiluminescence in human neutrophils in the absence of cytochalasin B.

Poitevin B, Roubin R, Benveniste J.

Immunopharmacology. 1984 Apr;7(2):135-44.

PMID:
6724877
35.

PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils.

Pirotzky E, Page CP, Roubin R, Pfister A, Paul W, Bonnet J, Benveniste J.

Microcirc Endothelium Lymphatics. 1984 Feb;1(1):107-22.

PMID:
6546141
36.

The role of immunomodulators in the production of lipid mediators by macrophages (M phi).

Roubin R, Drapier JC, Petit JF, Benveniste J.

Int J Tissue React. 1984;6(5):373-8.

PMID:
6596298
37.

Lipid-mediator synthesis in peritoneal macrophages from mice injected with immunostimulants.

Drapier JC, Roubin R, Petit JF, Benveniste J.

Biochim Biophys Acta. 1983 Mar 22;751(1):90-8.

PMID:
6131693
38.

Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types.

Benveniste J, Roubin R, Chignard M, Jouvin-Marche E, Le Couedic JP.

Agents Actions. 1982 Dec;12(5-6):711-3.

PMID:
7164945
39.
40.

Biosynthesis of platelet-activating factor (PAF-acether). IV. Impairment of acetyl-transferase activity in thioglycollate-elicited mouse macrophages.

Roubin R, Mencia-Huerta JM, Landes A, Benveniste J.

J Immunol. 1982 Aug;129(2):809-13. No abstract available.

PMID:
6806384
41.

Release of platelet-activating factor (PAF-acether) and leukotrienes C and D from inflammatory macrophages.

Roubin R, Mencia-Huerta JM, Benveniste J.

Eur J Immunol. 1982 Feb;12(2):141-6.

PMID:
6122581
42.

Lymphoid cells in lymph nodes and peripheral blood of patients with squamous cell carcinoma of the head and neck.

Roubin R, Bekkoucha F, Fondaneche MC, Quan PC, Micheau C, Cachin Y, Burtin P.

J Cancer Res Clin Oncol. 1982;102(3):277-87.

PMID:
6977544
43.

Is platelet-activating factor (PAF-acether) synthesis by murine peritoneal cells (PC) a two-step process?

Mencia-Huerta JM, Ninio E, Roubin R, Benveniste J.

Agents Actions. 1981 Dec;11(6-7):556-8.

PMID:
7053072
44.
45.

Markers of macrophage heterogeneity: altered frequency of macrophage subpopulations after various pathologic stimuli.

Roubin R, Kennard J, Foley D, Zolla-Pazner S.

J Reticuloendothel Soc. 1981 Jun;29(6):423-32. No abstract available.

PMID:
7265062
46.

Platelet-activating factor (PAF-acether): molecular aspects of its release and pharmacological actions.

Benveniste J, Jouvin E, Pirotzky E, Arnoux B, Mencia-Huerta JM, Roubin R, Vargaftig BB.

Int Arch Allergy Appl Immunol. 1981;66 Suppl 1:121-6. Review. No abstract available.

PMID:
7030966
47.
48.

Human peripheral Nullymphocytes: ultrastructural aspects of the "K" cell effect against a melanoma target cell.

Cesarini JP, Roubin R, Kalden JR, Peter HH.

Biomedicine. 1978 Jul-Aug;28(4):219-25.

PMID:
737273
49.

Human peripheral Null lymphocytes. I. Isolation, immunological and functional characterization.

Kalden JR, Peter HH, Roubin R, Cesarini JP.

Eur J Immunol. 1977 Aug;7(8):537-43. No abstract available.

PMID:
902681
50.

[Characterization of the infiltration of human malignant melanoma according to the nature of the receiving surface. I. Study of fragments of tumors].

Cesarini JP, Roubin R, Fridman WH, Mouly R.

Ann Dermatol Syphiligr (Paris). 1976;103(3):312-5. French. No abstract available.

PMID:
1008526

Supplemental Content

Loading ...
Support Center